100 related articles for article (PubMed ID: 16449698)
1. Neuroleptics and mortality: a 50-year cycle: Invited commentary on... Schizophrenia, neuroleptic medication and mortality.
Healy D
Br J Psychiatry; 2006 Feb; 188():128. PubMed ID: 16449698
[No Abstract] [Full Text] [Related]
2. Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia.
Krausz M; Moritz S; Lambert M; Naber D
Int Clin Psychopharmacol; 2000 Mar; 15(2):77-81. PubMed ID: 10759338
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia, neuroleptic medication and mortality.
Joukamaa M; Heliövaara M; Knekt P; Aromaa A; Raitasalo R; Lehtinen V
Br J Psychiatry; 2006 Feb; 188():122-7. PubMed ID: 16449697
[TBL] [Abstract][Full Text] [Related]
4. Clotiapine compared with chlorpromazine in chronic schizophrenia.
Geller V; Gorzaltsan I; Shleifer T; Belmaker RH; Bersudsky Y
Schizophr Res; 2005 Dec; 80(2-3):343-7. PubMed ID: 16126373
[TBL] [Abstract][Full Text] [Related]
5. The impact of neuroleptic dosage and extrapyramidal side effects on schizophrenic basic symptoms.
Moritz S; Krausz M; Gottwalz E; Andresen B
Compr Psychiatry; 2000; 41(4):284-8. PubMed ID: 10929797
[TBL] [Abstract][Full Text] [Related]
6. The introduction of neuroleptics: a psychiatric revolution.
Cancro R
Psychiatr Serv; 2000 Mar; 51(3):333-5. PubMed ID: 10686239
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic treatment and negative symptoms in deficit and nondeficit schizophrenia.
Bustillo JR; Kirkpatrick B; Buchanan RW
Biol Psychiatry; 1995 Jul; 38(1):64-7. PubMed ID: 7548474
[No Abstract] [Full Text] [Related]
8. Comparative effectiveness of antipsychotic drugs. A commentary on: Cost Utility Of The Latest Antipsychotic Drugs In Schizophrenia Study (CUtLASS 1) and Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE).
Lieberman JA
Arch Gen Psychiatry; 2006 Oct; 63(10):1069-72. PubMed ID: 17015808
[No Abstract] [Full Text] [Related]
9. Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients.
Montout C; Casadebaig F; Lagnaoui R; Verdoux H; Philippe A; Begaud B; Moore N
Schizophr Res; 2002 Oct; 57(2-3):147-56. PubMed ID: 12223245
[TBL] [Abstract][Full Text] [Related]
10. Re: From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma.
Nardi AE
Can J Psychiatry; 2004 Nov; 49(11):784; author reply 784. PubMed ID: 15633857
[No Abstract] [Full Text] [Related]
11. All-cause mortality and medication risk factors in schizophrenia: a prospective cohort study.
Tenback D; Pijl B; Smeets H; Os Jv; Harten Pv
J Clin Psychopharmacol; 2012 Feb; 32(1):31-5. PubMed ID: 22198442
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine: new preparation. Keep an eye on this neuroleptic.
Prescrire Int; 1999 Oct; 8(43):135-8. PubMed ID: 11503836
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic-induced reductions in serum dopamine-beta-hydroxylase in schizophrenia.
Goodnick PJ; Tong C; Duncavage MB; Meltzer HY
Biol Psychiatry; 1983 Dec; 18(12):1485-8. PubMed ID: 6140962
[No Abstract] [Full Text] [Related]
14. Cessation of medication for people with schizophrenia already stable on chlorpromazine.
Almerie MQ; Matar HE; Essali A; Alkhateeb H; Rezk E
Schizophr Bull; 2008 Jan; 34(1):13-4. PubMed ID: 17984296
[No Abstract] [Full Text] [Related]
15. [A neuroleptic malignant syndrome complicated by subarachnoid hemorrhage and revealing cerebral vasculitis].
Jouali T; Boukatta B; Bechri B; Houari N; Bouazzaoui A; Sbai H; Kanjaa N
Pan Afr Med J; 2014; 19():247. PubMed ID: 25852790
[TBL] [Abstract][Full Text] [Related]
16. Mortality in schizophrenia.
Hasnain M; Vieweg WV; Mezuk B
J Psychopharmacol; 2011 Jun; 25(6):846-7. PubMed ID: 21421641
[No Abstract] [Full Text] [Related]
17. Treatment with neuroleptics: the patient's perspective.
Windgassen K
Acta Psychiatr Scand; 1992 Nov; 86(5):405-10. PubMed ID: 1362474
[TBL] [Abstract][Full Text] [Related]
18. Self-reported prescribing practices for schizophrenic patients among Israeli psychiatrists.
Heresco-Levy U; Brom D; Greenberg D
Isr J Psychiatry Relat Sci; 1993; 30(3):164-74. PubMed ID: 7901179
[TBL] [Abstract][Full Text] [Related]
19. Approaching long-term neuroleptic treatment of schizophrenia.
Hansell N
JAMA; 1979 Sep; 242(12):1293-4. PubMed ID: 39181
[TBL] [Abstract][Full Text] [Related]
20. [Dynamics of integral parameters of the background EEG during treatment with neuroleptics].
Bochkarev VK; Paniushkina SV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):258-64. PubMed ID: 6122319
[No Abstract] [Full Text] [Related]
[Next] [New Search]
